기업 프로필 · Technology

Consensus Cloud Solutions Inc

CCSI · 미국
국가 / 지역
USA
상장일
2021년 10월 8일
직원 수
520
웹사이트
www.consensus.com
Buffett Score
69/100
우수
시가총액US$6.48억
매출 (TTM)US$3.55억
EBITDAUS$1.68억
순이익률26.69%
ROE12.55%
PER (TTM)7.17
선행 PER5.91
EPSUS$4.93
52주 범위US$20.20 – US$41.40
애널리스트 목표주가US$42.25
애널리스트 평가5.0 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

Consensus Cloud Solutions, Inc., together with its subsidiaries, provides information delivery services with a software-as-a-service platform in the United States, Canada, Ireland, and internationally. The company offers eFax Corporate, a digital cloud fax technology; ECFax for use by public sector customers with extremely high security demands; and eFax Unite, a single platform that allows the user to choose between various protocols to send and receive healthcare information in an environment that can integrate into an existing electronic health record system or stand-alone if no electronic health record (EHR) is present. It also offers jSign, an electronic and digital signature solution; eFax Conductor, an interface engine and interoperability platform that provides integration technology; eFax Clarity that transforms unstructured documents into structured actionable data; and eFax, an online faxing solution, as well as other products under the MyFax, Sfax, MetroFax, and SRfax brands. In addition, the company offers Clarity Clinical Documentation (CD), a clinical documentation software; eFax Harmony, an API for healthcare; eFax All Access for care coordination; and artificial intelligence, clinical documentation, HIPAA compliance, natural language processing, interoperability, eSignatures, and cloud fax solutions. It serves individuals and small businesses; and the healthcare, government, financial services, law, education, insurance, manufacturing, and real estate sectors. Consensus Cloud Solutions, Inc. was incorporated in 2021 and is headquartered in Los Angeles, California.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.